Compiled all in one place, read news articles from each of the news categories, about drugs, the pharmaceutical industry, national and international awareness causes, scientific meetings, trending stories and epgonline.org headlines.

Drug News

Added 2 hours ago Drug news

IDMC recommends early halt of phase III SANET-p study of HMPL 012 in neuroendocrine tumors – pancreatic.- Hutchison China MediTech

Hutchison China MediTech Limited announced that the independent Data Monitoring Committee of the Phase III pivotal study of HMPL 012...

Added 2 hours ago Drug news

EU approves Darzalex + Velcade + Thalomid + dexamethasone in newly diagnosed multiple myeloma.- Genmab

Genmab announced that the European Commission (EC) has granted marketing authorization for Darzalex (daratumumab) in combination with Velcade (bortezomib), Thalomid(thalidomide)...

Added 2 hours ago Drug news

FDA accepts filing of NDA for Lynparza for patients with metastatic castration-resistant prostate cancer . AstraZeneca + Merck Inc.

AstraZeneca and MSD Inc.,announced that a supplemental New Drug Application for Lynparza (olaparib) has been accepted and granted Priority Review...

Added 2 hours ago Drug news

European Commission approval for Mayzent to treat secondary progressive multiple sclerosis.- Novartis

Novartis announced the European Commission (EC) has approved Mayzent (siponimod) for the treatment of adult patients with secondary progressive multiple...

Industry news

Added 4 days ago Industry news

BioNTech acquires Neon Therapeutics and NEO-PTC-01, a personalised neoantigen-targeted T cell therapy

BioNTech and Neon Therapeutics, Inc. announced that they have entered into a definitive merger agreement under which BioNTech will acquire...

Added 10 days ago Industry news

Eli Lilly to acquire Dermira and with it lebrikizumab, a treatment for atopic dermatitis

Eli Lilly and Company announced a definitive agreement for Lilly to acquire Dermira for $18.75 per share, or approximately $1.1...

Added 11 days ago Industry news

AbbVie creates Allergan Aesthetics for development and marketing of aesthetic products

AbbVie announced the creation of a new global business, Allergan Aesthetics, an AbbVie company, and the proposed leadership team for...